Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Johnson & Johnson Surgical Vision, Inc.

United States·US-MF-000038968

Last updated September 17, 2026

About

We want you to see better. Learn more about eye treatments and solutions for your eye health and vision needs at every stage of life.

Translated from the manufacturer's own website. Source

What Johnson & Johnson Surgical Vision, Inc. makes

The company manufactures posterior-chamber intraocular lenses (IOLs) for pseudophakic use, including single-piece and multifocal designs, as well as intraocular lens-insertion cartridges for surgical implantation. These devices are intended for cataract patients undergoing lens replacement procedures.

The portfolio includes Class IIb and Class III devices, with listings in the EU’s eudamed registry and the FDA’s Unique Device Identifier (UDI) database. The manufacturer is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Johnson & Johnson Surgical Vision, Inc. manufacture?

Johnson & Johnson Surgical Vision, Inc. specializes in posterior-chamber intraocular lenses (IOLs) designed for pseudophakic use, which replace the natural lens during cataract surgery. Their portfolio also includes intraocular lens-insertion cartridges, which assist in the precise surgical implantation of these lenses. These devices are tailored for patients undergoing lens replacement procedures to restore vision clarity.

Where is Johnson & Johnson Surgical Vision, Inc. based, and what does that mean for its regulatory oversight?

Johnson & Johnson Surgical Vision, Inc. is based in the United States. This means its devices are subject to regulatory oversight by the FDA (Food and Drug Administration) in the U.S., while their European listings appear in the EU’s eudamed registry, reflecting compliance with EU medical device regulations. The company’s U.S. and EU operations ensure its products meet both regional standards for safety and performance.

Which regulatory registries list Johnson & Johnson Surgical Vision, Inc.’s devices, and why does this matter?

Johnson & Johnson Surgical Vision, Inc.’s devices are listed in the EU’s eudamed registry and the FDA’s Unique Device Identifier (UDI) database. These registries are critical because they provide transparent, searchable records of device details (e.g., model numbers, classifications) for healthcare professionals, regulators, and patients. Listing in these systems ensures traceability and compliance with global medical device reporting requirements.

How are Johnson & Johnson Surgical Vision, Inc.’s intraocular lenses classified under medical device regulations?

Johnson & Johnson Surgical Vision, Inc.’s intraocular lenses fall into Class IIb and Class III categories under medical device regulations. Class III designation applies to higher-risk devices (e.g., those supporting or sustaining life, or posing significant risks if they fail), while Class IIb covers devices with moderate risks, such as certain IOLs. This classification influences manufacturing controls, clinical evaluations, and post-market surveillance requirements to ensure safety and efficacy.

Why do some of Johnson & Johnson Surgical Vision, Inc.’s devices have different model numbers (e.g., ZCT4500140 vs. ZXT300I280), and what do these indicate?

The varied model numbers (e.g., ZCT4500140, ZXT300I280) reflect differences in design, functionality, or intended use within the company’s portfolio. For example, some may represent variations in lens optics (e.g., single-piece vs. multifocal), cartridge compatibility, or surgical application methods. These distinctions are critical for healthcare providers to select the appropriate device for a patient’s specific needs, as they influence outcomes like vision correction and surgical ease.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
United States
Address
Suite 200, 31 Technology Drive, Irvine, United States
LinkedIn
—
Phone
+1 714-227-8729
PRRC Contact
Gary Leaf
EUDAMED SRN
US-MF-000038968
FDA FEI Number
3012236936
DUNS Number
—

Catalogue (6112)

Page 3 of 123
DeviceModel / ReferenceRegistriesClassStatus
Zcu400i235 ZCU400I235
EUDAMED
Class IIbActive
Zct7000150 ZCT7000150
EUDAMED
Class IIbActive
Zct6000260 ZCT6000260
EUDAMED
Class IIbActive
Zct1000210 ZCT1000210
EUDAMED
Class IIbActive
Zmt300i300 ZMT300I300
EUDAMED
Class IIbActive
Zct6000215 ZCT6000215
EUDAMED
Class IIbActive
Zxt300i050 ZXT300I050
EUDAMED
Class IIbActive
Zct8000075 ZCT8000075
EUDAMED
Class IIbActive
Zct3000210 ZCT3000210
EUDAMED
Class IIbActive
Zct4500300 ZCT4500300
EUDAMED
Class IIbActive
Zct4500050 ZCT4500050
EUDAMED
Class IIbActive
Zxt300i250 ZXT300I250
EUDAMED
Class IIbActive
Zct4000330 ZCT4000330
EUDAMED
Class IIbActive
Zct4500070 ZCT4500070
EUDAMED
Class IIbActive
Zct1000245 ZCT1000245
EUDAMED
Class IIbActive
Zmt400i080 ZMT400I080
EUDAMED
Class IIbActive
Zct6000180 ZCT6000180
EUDAMED
Class IIbActive
Zct7000290 ZCT7000290
EUDAMED
Class IIbActive
Zct8000145 ZCT8000145
EUDAMED
Class IIbActive
Zct3000205 ZCT3000205
EUDAMED
Class IIbActive
Zxt300i185 ZXT300I185
EUDAMED
Class IIbActive
Zct8000215 ZCT8000215
EUDAMED
Class IIbActive
Zct3000175 ZCT3000175
EUDAMED
Class IIbActive
Zct8000310 ZCT8000310
EUDAMED
Class IIbActive
Zxt300i155 ZXT300I155
EUDAMED
Class IIbActive
Zct3000240 ZCT3000240
EUDAMED
Class IIbActive
Zct7000160 ZCT7000160
EUDAMED
Class IIbActive
Zmt400i120 ZMT400I120
EUDAMED
Class IIbActive
Zcu400i150 ZCU400I150
EUDAMED
Class IIbActive
Zct3000165 ZCT3000165
EUDAMED
Class IIbActive
Zxt300i270 ZXT300I270
EUDAMED
Class IIbActive
Zct7000165 ZCT7000165
EUDAMED
Class IIbActive
Zct4000235 ZCT4000235
EUDAMED
Class IIbActive
Zct4000285 ZCT4000285
EUDAMED
Class IIbActive
Zct6000110 ZCT6000110
EUDAMED
Class IIbActive
Zct6000140 ZCT6000140
EUDAMED
Class IIbActive
Zct7000180 ZCT7000180
EUDAMED
Class IIbActive
Zcu400i245 ZCU400I245
EUDAMED
Class IIbActive
Zmt400i110 ZMT400I110
EUDAMED
Class IIbActive
Zmt400i310 ZMT400I310
EUDAMED
Class IIbActive
Zcu400i110 ZCU400I110
EUDAMED
Class IIbActive
Zct7000235 ZCT7000235
EUDAMED
Class IIbActive
Zmt400i250 ZMT400I250
EUDAMED
Class IIbActive
Zct7000305 ZCT7000305
EUDAMED
Class IIbActive
Zct7000125 ZCT7000125
EUDAMED
Class IIbActive
Zct1000105 ZCT1000105
EUDAMED
Class IIbActive
Zct4000125 ZCT4000125
EUDAMED
Class IIbActive
Zct7000285 ZCT7000285
EUDAMED
Class IIbActive
Zct4000295 ZCT4000295
EUDAMED
Class IIbActive
Zct1000270 ZCT1000270
EUDAMED
Class IIbActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (17)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Johnson & Johnson Surgical Vision, Inc. has 17 recall records initiated between May 9, 2018, and March 14, 2024, with statuses including open, classified, and terminated. The reasons cited involve intraocular lenses with specification deviations (e.g., cylinder axis misalignment, unintended toric marks, or expired distribution), software failures affecting alignment verification, packaging errors (e.g., incorrect cutter sizes or broken irrigation luer components), and manufacturing issues with devices like ophthalmic viscosurgical tools and phacoemulsification systems. Some records mention potential sterility breaches, endotoxin contamination, and nonconforming product releases.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Mar 14, 2024Z-1755-2024—open, classified

Due to a manufacturing variation of the irrigation sleeves which could result in a missing port hole, this non-conformity could lead to insufficient flow to cool the ultrasonic phaco tip, potentially leading to an unstable anterior chamber which could cause possible harms.

Dec 12, 2023Z-0735-2024—open, classified

Due to intraocular lens containing an angle out of specification (OOS). The cylinder axis marks do not meet product specifications for the allowable angle between Low Power Meridian (LPM) and toric cylinder axis marks.

Jul 6, 2023Z-2289-2023—open, classified

Their is a potential that intraocular lenses (IOLs) were manufactured with unintended toric fiducial marks.

Jul 6, 2023Z-2288-2023—open, classified

Their is a potential that intraocular lenses (IOLs) were manufactured with unintended toric fiducial marks.

May 30, 2023Z-2247-2023—open, classified

Weld protrusion/physical gap between the housing and pack cover, may exceed design specification, due to a manufacturing issue, which could lead to priming cycle failure and/or suboptimal vacuum delivered to the phacoemulsification and irrigation/aspiration handpieces during surgery, which could result in surgical delay and/or longer surgical time, which could result in transient corneal edema.

Dec 7, 2022Z-1006-2023—open, classified

Weld protrusion/physical gap between the housing and phaco pack cover, may exceed design specification, which could lead to priming cycle failure and/or suboptimal vacuum delivered to the phacoemulsification and irrigation/aspiration handpieces during surgery, which could result in surgical delay and/or longer surgical time, which could result in transient corneal edema.

Dec 7, 2022Z-1007-2023—open, classified

Weld protrusion/physical gap between the housing and phaco pack cover, may exceed design specification, which could lead to priming cycle failure and/or suboptimal vacuum delivered to the phacoemulsification and irrigation/aspiration handpieces during surgery, which could result in surgical delay and/or longer surgical time, which could result in transient corneal edema.

Dec 7, 2022Z-1005-2023—open, classified

Weld protrusion/physical gap between the housing and phaco pack cover, may exceed design specification, which could lead to priming cycle failure and/or suboptimal vacuum delivered to the phacoemulsification and irrigation/aspiration handpieces during surgery, which could result in surgical delay and/or longer surgical time, which could result in transient corneal edema.

Sep 7, 2022Z-0169-2023—open, classified

Manufacturing error resulted in potential contamination of Bi-Directional navigation catheter irrigation path with cellulose fibers that can cause 1) Failure of initial flushing inspection, 2) Insufficient irrigation causing catheter tip temperature increase, limiting the ability to deliver ablation, or 3) particles flushed through the catheter irrigation may have thrombogenic/toxic effect.

Sep 1, 2022Z-0086-2023—open, classified

As a result of returned product complaints for Veritas Phaco packs related to broken or cracked irrigation luer due to a manufacturing issue.

Apr 6, 2022Z-1033-2022—open, classified

Potential breach in the sterility barrier for tray ring covers.

Aug 6, 2021Z-0028-2022—terminated

Nonconforming product was distributed in error. Product was nonconforming due endotoxin levels higher than both the Firm's internal endotoxin specification limit and the FDA recommended endotoxin specification limit. Product was released in error based on the results of additional testing performed during the investigation into release testing nonconformance.

Jan 27, 2021Z-1163-2021—terminated

Due to the release of nonconforming Intraocular Lenses (IOLs).

Dec 3, 2019Z-0867-2020—terminated

Ophthalmic viscosurgical device may be difficult to remove from the eye, leading to increased postoperative intraocular pressure requiring additional intervention. Also, reports of clogging of phacoemulsion equipment tubing, which may lead to delay in the procedure or ocular injury.

Sep 24, 2018Z-1893-2019—terminated

Packaging error, 20GA Vitrectomy Cutter may be found in a 25GA package. Use of a Vitrectomy cutter that is a different size than expected could lead to the need to alter the surgical technique, including corneal incision enlargement.

Jun 21, 2018Z-0464-2019—terminated

Expired intraocular lenses were distributed.

May 9, 2018Z-0066-2019—terminated

Software upgrade exhibits failures when executing Daily Alignment Verification (DAV), specifically, cuts on the plastic hemisphere during DAV do not match the intended cuts shown on the treatment overlay screen on the system GUI.